胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)多克隆抗體(生物素標(biāo)記)
Biotin-Linked Polyclonal Antibody to Insulin Like Growth Factor Binding Protein 3 (IGFBP3)
BP53; IBP3; Growth Hormone-Dependent Binding Protein; Acid Stable Subunit Of The 140 K IGF Complex
- 編號(hào)LAA054Hu71
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來(lái)源抗體標(biāo)記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物生物素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC.
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 446 ¥ 1042 ¥ 1488 ¥ 3720 ¥ 14880
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對(duì)IGFBP3的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別IGFBP3。
用法
免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學(xué):5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA054Hu01 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA054Hu01 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA054Hu03 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA054Hu02 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA054Hu61 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA054Hu62 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA054Hu02 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA054Hu01 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)多克隆抗體 | WB; IHC; ICC; IP. |
LAA054Hu71 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA054Hu22 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA054Hu25 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA054Hu27 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA054Hu29 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA054Hu21 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA054Hu23 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)單克隆抗體 | WB; IHC; ICC; IP. |
MAA054Hu24 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)單克隆抗體 | WB |
SEA054Hu | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA054Hu | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA054Hu01 | 胰島素樣生長(zhǎng)因子結(jié)合蛋白3(IGFBP3)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Molecular Biology Reports | Characterization of the specific and sustained GH1 expression induced by rAAV2/1 in normal adult male rats [PubMed: 20204528] |
Endocrinology | Role of IGFBP-3 in the Regulation of β-Cell Mass during Obesity: Adipose Tissue/β-Cell Cross Talk [Endo: source] |
Nutrition and Cancer | A Pilot Study Comparing the Effect of Flaxseed, Aromatase Inhibitor, and the Combination on Breast Tumor Biomarkers [Tandfonline: Source] |
Dig Dis Sci | The Protective Effects of Exclusive Enteral Nutrition Formulas on Growth Factor Expression and the Proximal Tibial Epiphyseal Growth Plate in a TNBS-Induced IBD Rat Model [PubMed: 25708898] |
Animal. | Effects of a dietary crude fibre concentrate on growth in weaned piglets. [pubmed:28318464] |
PLoS One | Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia [Pubmed: 32191705] |
Int J Environ Res Public Health | Association of Salivary IGF and IGF/IGFBP-3 Molar Ratio with Cervical Vertebral Maturation Stages from Pre-Adolescent to Post-Adolescent Transition Period—A?… [Pubmed:35564566] |